AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MANNKIND CORP Director's Dealing 2022

Aug 25, 2022

31835_dirs_2022-08-24_e129ecee-0583-47af-b0ac-69538488a1f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2022-07-31

Reporting Person: Galindo Alejandro (EVP Endocrine Business Unit)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-31	Common Stock, $0.01 Par Value	A	5000	$2.93	Acquired	781690	Direct

Footnotes

F1: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022.